CVE-2026-32168Azure Monitor Agent Elevation of Privilege Vulnerability
Updated under an hour ago ()
Does this affect you?
It affects Microsoft Azure Monitor and 1 other product. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
Improper input validation in Azure Monitor Agent allows an authorized attacker to elevate privileges locally.
- CVSS
- 7.8 HIGH (v3.1, CNA)CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H/E:U/RL:O/RC:C
- Weakness (CWE)
- CWE-20
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- microsoft
- NVD analysis
- Analyzed
- Record last updated
- Oct 15, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
Microsoft Azure Monitor microsoft:azure_monitor (from the name) | from 1.0.0 before 1.35.9 | CNA record |
microsoft azure_monitor_agent microsoft:azure_monitor_agent | before 1.35.9 | NVD |
References
- https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-32168vendor-advisory, patch
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.